NASDAQ$EXPO
Exponent Inc. · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Exponent reported solid second quarter results with revenue growth and expanded earnings per diluted share.
Exponent's Q2 2023 showed a 9.7% increase in revenues before reimbursements, reaching $129.7 million, and earnings per diluted share increased to $0.50. Growth was driven by demand for reactive offerings and increased demand in the chemicals and life sciences sectors.
- Total revenues increased by 7.6% to $140.2 million compared to the second quarter of 2022.
- Revenues before reimbursements increased by 9.7% to $129.7 million compared to the second quarter of 2022.
- Net income was $25.7 million, or $0.50 per diluted share.
- The company's engineering and other scientific segment represented 83% of the Company’s revenues before reimbursements.
Headline financials
Revenue & EPS history
Exponent · Revenue · Quarterly
$140M
Revenue by segment
Exponent · $1 total across 2 segments · Q2 2023
- Engineering & Other Scientific$0.83—83.0%
- Environmental & Health$0.17—17.0%
Forward guidance
Exponent is maintaining its revenue and margin guidance for the full 2023 fiscal year.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
+0.5%
Avg return
Earnings day
+0.4%
Avg return
5 days after
+2.7%
Avg return
30 days after
52%
33 / 63 earnings
Positive
+18.1%
Q1 2024
Best reaction
-12.4%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.5% | -4.0% | -12.8% | |
| Q4 2025 | +12.7% | +1.3% | +1.5% | |
| Q3 2025 | +7.9% | +10.2% | +8.2% | |
| Q1 2025 | -1.5% | -3.8% | -1.9% | |
| Q4 2024 | +1.2% | +0.8% | -4.8% | |
| Q3 2024 | -9.5% | -8.7% | -8.5% | |
| Q2 2024 | +0.2% | +1.7% | +1.0% | |
| Q1 2024 | +18.1% | +14.0% | +19.5% | |
| Q4 2023 | -11.1% | -11.2% | -8.5% | |
| Q3 2023 | -12.4% | -11.7% | -6.5% | |
| Q2 2023 | -6.3% | -7.1% | -4.8% | |
| Q1 2023 | -2.3% | -3.7% | -2.4% | |
| Q4 2022 | +7.4% | +5.5% | +1.8% | |
| Q3 2022 | +3.6% | +7.1% | +13.0% | |
| Q2 2022 | +5.9% | +3.1% | +3.1% | |
| Q1 2022 | -5.6% | -9.9% | -10.4% | |
| Q4 2021 | -10.1% | -8.4% | +3.8% | |
| Q3 2021 | +2.7% | +2.4% | +4.4% | |
| Q2 2021 | +9.0% | +11.5% | +17.9% | |
| Q1 2021 | -0.6% | -1.2% | -5.9% | |
| Q4 2020 | +3.2% | +8.8% | +9.0% | |
| Q3 2020 | -3.7% | +0.4% | +15.4% | |
| Q2 2020 | +2.1% | +0.3% | +0.0% | |
| Q1 2020 | -5.8% | -7.2% | +4.4% | |
| Q3 2019 | -5.5% | -7.3% | -8.6% | |
| Q2 2019 | +9.4% | +10.7% | +17.4% | |
| Q1 2019 | -0.8% | -0.2% | -0.1% | |
| Q4 2018 | +1.2% | +3.3% | +14.7% | |
| Q3 2018 | +0.7% | +1.7% | +9.3% | |
| Q2 2018 | -3.0% | -0.6% | +0.9% | |
| Q1 2018 | +1.3% | +1.1% | +11.1% | |
| Q4 2017 | +3.2% | +1.3% | +3.2% | |
| Q3 2017 | -3.4% | -2.4% | -1.5% | |
| Q2 2017 | +13.7% | +11.5% | +10.3% | |
| Q1 2017 | +1.7% | +1.6% | +0.3% | |
| Q4 2016 | -3.1% | +0.0% | +0.8% | |
| Q3 2016 | +10.3% | +15.5% | +23.3% | |
| Q2 2016 | -11.2% | -11.2% | -13.7% | |
| Q1 2016 | -0.2% | — | — | |
| Q4 2015 | +2.4% | — | — | |
| Q3 2015 | +6.8% | — | — | |
| Q2 2015 | -0.6% | — | — | |
| Q1 2015 | +6.9% | — | — | |
| Q4 2014 | +8.5% | — | — | |
| Q3 2014 | +0.5% | — | — | |
| Q2 2014 | +6.4% | — | — | |
| Q1 2014 | -3.0% | — | — | |
| Q4 2013 | +0.1% | — | — | |
| Q3 2013 | +3.9% | — | — | |
| Q2 2013 | -0.8% | — | — | |
| Q1 2013 | +0.8% | — | — | |
| Q4 2012 | -11.5% | — | — | |
| Q3 2012 | +1.6% | — | — | |
| Q2 2012 | -0.5% | — | — | |
| Q1 2011 | -1.8% | — | — | |
| Q1 2012 | +1.1% | — | — | |
| Q4 2011 | +3.7% | — | — | |
| Q1 2010 | +3.7% | — | — | |
| Q3 2010 | -2.3% | — | — | |
| Q3 2011 | -2.3% | — | — | |
| Q2 2011 | -2.0% | — | — | |
| Q4 2010 | -2.0% | — | — | |
| Q2 2010 | -2.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro